Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03UUO
|
|||
Former ID |
DNC007454
|
|||
Drug Name |
2-(2-(butylamino)pyrimidin-4-ylamino)benzoic acid
|
|||
Synonyms |
4-anilinopyrimidine 7a; CHEMBL394869; BDBM15986; AKOS029246132; 2-{[2-(butylamino)pyrimidin-4-yl]amino}benzoic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H18N4O2
|
|||
Canonical SMILES |
CCCCNC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O
|
|||
InChI |
1S/C15H18N4O2/c1-2-3-9-16-15-17-10-8-13(19-15)18-12-7-5-4-6-11(12)14(20)21/h4-8,10H,2-3,9H2,1H3,(H,20,21)(H2,16,17,18,19)
|
|||
InChIKey |
FSZJHCURVIQYSG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies. Bioorg Med Chem Lett. 2007 Feb 1;17(3):668-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.